Nurix Therapeutics Inc (NRIX) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Nurix Therapeutics Inc   (NASDAQ: NRIX)


Nurix Therapeutics Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



NRIX Gross Profit Margin (May 31 2026)
Q2
(Feb 28 2026)
Q1
(Nov 30 2025)
Q4
(Aug 31 2025)
Q3
(May 31 2025)
Q2
Y / Y Revenue Change -79.47 %
Seq. Revenue Change 44.64 %
Revenue In Millions $9.04
Gross Profit Margin 0 %
Gross Profit Margin Total Ranking # 641
Gross Profit In Millions $0.00
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting Second Quarter 2026 Gross Profit Margin



Observing second quarter 2026 results within Major Pharmaceutical Preparations industry 91 other companies have achieved higher Gross Profit Margin. While overall Gross Profit Margin ranking remained unchanged compared to the previous quarter at no. .
Learn about Gross Margin
NRIX's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 92
Healthcare Sector # 162
Overall # 641

Gross Profit Margin Statistics
High Average Low
100 % 100 % 100 %
(Feb 28 2026)  




Other Gross Profit Margin Profitability Ratios
NRIX's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
NRIX's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for NRIX's Competitors
Gross Profit Margin Profit Margin for Nurix Therapeutics Inc 's Suppliers
Gross Profit Margin Profit Margin for NRIX's Customers

You may also want to know
NRIX's Annual Growth Rates NRIX's Profitability Ratios NRIX's Asset Turnover Ratio NRIX's Dividend Growth
NRIX's Roe NRIX's Valuation Ratios NRIX's Financial Strength Ratios NRIX's Gross Profit Growth
NRIX's Roa NRIX's Inventory Turnover Ratio NRIX's Growth Rates NRIX's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending May 31 2026, within Major Pharmaceutical Preparations Industry Gross Profit MarginMay 31 2026 MRQ Gross ProfitMay 31 2026 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.